Valuation: Cello Health plc

Market Cap 179M 153M 143M 131M 247M 17.06B 250M 1.69B 659M 8.6B 671M 657M 28.47B P/E 2018
18.1x
P/E 2019 -155x
Enterprise Value 182M 156M 146M 134M 252M 17.4B 255M 1.72B 672M 8.77B 685M 670M 29.04B EV / Sales 2018
0.66x
EV / Sales 2019 0.88x
Free-Float
-
Yield 2018
3.47%
Yield 2019 1.6%
Manager TitleAgeSince
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 51 2020-08-12
Director/Board Member 47 2023-12-14
Date Insider Type Main position Quantity % Market Cap.
3/30/20 Free 80,000 0.0752%
3/30/20 Free

Chief Operating Officer

265,000 0.2492%
3/30/20 Free

Chief Financial Officer

250,000 0.2351%

Financials

2018 2019
Net sales 166M 142M 133M 121M 229M 15.8B 231M 1.56B 610M 7.96B 622M 608M 26.36B 167M 143M 134M 122M 231M 15.91B 233M 1.58B 614M 8.02B 626M 612M 26.55B
Net income 6.62M 5.67M 5.3M 4.85M 9.16M 631M 9.24M 62.55M 24.37M 318M 24.85M 24.31M 1.05B -943K -808K -756K -691K -1.3M -89.96M -1.32M -8.91M -3.47M -45.32M -3.54M -3.46M -150M
Net Debt -6.34M -5.43M -5.08M -4.65M -8.77M -605M -8.85M -59.93M -23.35M -305M -23.81M -23.29M -1.01B 3.58M 3.06M 2.87M 2.62M 4.95M 341M 4.99M 33.81M 13.17M 172M 13.43M 13.14M 569M
Logo Cello Health plc
Cello Health plc, formerly Cello Group plc, is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company provides a range of biotech, diagnostics, devices and other non-healthcare clients. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States and Singapore.
Employees
-
Sector
-